Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bavanthi Balakrishnar

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Internal Medicine Journal|January 30, 2019
Patterns of immunotherapy use and management of toxicities in regional and tertiary settingsBrett Hamilton, Kay Xu, Florian Honeyball, et al.
Clinical Genitourinary Cancer|August 4, 2022
Review of Toxicities of PARP Inhibitors in Metastatic Castrate Resistant Prostate CancerUdit Nindra, Jun Hee Hong, Bavanthi Balakrishnar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Evidence for therapeutic drug monitoring of targeted anticancer therapiesBo Gao, Shang Yeap, Arthur Clements, et al.
Case Reports in Oncology|January 6, 2023
A Rare Case of Castrate-Resistant Prostate Adenocarcinoma with a Unilateral Testicular Metastasis Mimicking a Primary Testicular TumourJun Hee Hong, Udit Nindra, Rebecca Nguyen, et al.
Journal for Immunotherapy of Cancer|May 22, 2026
Novel treatments for novel side effects: a case report and review of baricitinib use in the treatment of chronic inflammatory demyelinating polyneuropathy caused by immune checkpoint inhibitor useSana Haider, Wei Chua, Bavanthi Balakrishnar, et al.
Clinical Genitourinary Cancer|May 29, 2024
Adherence Outcomes and Risk Factors Predicting Nonadherence to Active Surveillance in Patients With Stage 1 Testicular Germ Cell TumorsRoger Liang, Diana Adams, Felicia Roncolato, et al.
Cancer Chemotherapy and Pharmacology|July 2, 2017
Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoringDhanusha Sabanathan, Alison Zhang, Peter Fox, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 9, 2026
Androgen Receptor Variant 7 (AR-V7) Transcript Expression in Circulating Tumor CellsTanzila Khan, Yafeng Ma, Alison Luk, et al.
Clinical Genitourinary Cancer|April 3, 2019
Patterns of Presentation and Treatment Outcomes of Non-clear-cell Renal Cell Carcinoma and Sarcomatoid Renal Cell Carcinoma Patients in 2 Tertiary Referral Centers in Sydney, AustraliaSayeda Naher, Shamsudheen Padinharakam, Bavanthi Balakrishnar, et al.
International Journal of Molecular Sciences|August 17, 2016
Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood BiopsiesYafeng Ma, Alison Luk, Francis P Young, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Internal Medicine Journal|January 30, 2019
Patterns of immunotherapy use and management of toxicities in regional and tertiary settingsBrett Hamilton, Kay Xu, Florian Honeyball, et al.
Clinical Genitourinary Cancer|August 4, 2022
Review of Toxicities of PARP Inhibitors in Metastatic Castrate Resistant Prostate CancerUdit Nindra, Jun Hee Hong, Bavanthi Balakrishnar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Evidence for therapeutic drug monitoring of targeted anticancer therapiesBo Gao, Shang Yeap, Arthur Clements, et al.
Case Reports in Oncology|January 6, 2023
A Rare Case of Castrate-Resistant Prostate Adenocarcinoma with a Unilateral Testicular Metastasis Mimicking a Primary Testicular TumourJun Hee Hong, Udit Nindra, Rebecca Nguyen, et al.
Journal for Immunotherapy of Cancer|May 22, 2026
Novel treatments for novel side effects: a case report and review of baricitinib use in the treatment of chronic inflammatory demyelinating polyneuropathy caused by immune checkpoint inhibitor useSana Haider, Wei Chua, Bavanthi Balakrishnar, et al.
Clinical Genitourinary Cancer|May 29, 2024
Adherence Outcomes and Risk Factors Predicting Nonadherence to Active Surveillance in Patients With Stage 1 Testicular Germ Cell TumorsRoger Liang, Diana Adams, Felicia Roncolato, et al.
Cancer Chemotherapy and Pharmacology|July 2, 2017
Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoringDhanusha Sabanathan, Alison Zhang, Peter Fox, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 9, 2026
Androgen Receptor Variant 7 (AR-V7) Transcript Expression in Circulating Tumor CellsTanzila Khan, Yafeng Ma, Alison Luk, et al.
Clinical Genitourinary Cancer|April 3, 2019
Patterns of Presentation and Treatment Outcomes of Non-clear-cell Renal Cell Carcinoma and Sarcomatoid Renal Cell Carcinoma Patients in 2 Tertiary Referral Centers in Sydney, AustraliaSayeda Naher, Shamsudheen Padinharakam, Bavanthi Balakrishnar, et al.
International Journal of Molecular Sciences|August 17, 2016
Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood BiopsiesYafeng Ma, Alison Luk, Francis P Young, et al.
Pageof 3